The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hannah Alison L. since 2017.
This trader's CIK number is 1645600.
At the time of last reporting, Hannah Alison L. was the Director of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NEO | 0 | $0 | 0 | $0 | 11,336 | $0 |
| 2020 | NEO | 0 | $0 | 0 | $0 | 10,000 | $72,700 |
| 2019 | NEO | 0 | $0 | 0 | $0 | 11,666 | $91,986 |
| 2017 | NEO | 20,000 | $183,800 | 0 | $0 | 13,889 | $44,402 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | CTMX | 0 | $0 | 5,602 | $7,966 | 0 | $0 |
2. Cytomx Therapeutics, Inc. (CTMX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-10 | NEO | Option Ex | 11,336 | .00 | 0 |
| 2020-08-06 | NEO | Option Ex | 10,000 | 7.27 | 72,700 |
| 2019-09-09 | NEO | Option Ex | 11,666 | 7.88 | 91,986 |
| 2017-08-09 | NEO | Option Ex | 6,667 | 6.66 | 44,402 |
| 2017-07-27 | NEO | Buy | 20,000 | 9.19 | 183,800 |
| 2017-05-30 | NEO | Option Ex | 7,222 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-20 | CTMX | Sale | 5,602 | 1.42 | 7,966 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hannah Alison L. (Director of Neogenomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.